Table 3.
Multivariate Analysis of Risk of Complication for Patients Who Were Diagnosed With COVID-19 Within 3 mo of TJA.
| Complication | OR (95% CI) | P-Value |
|---|---|---|
| Superficial surgical site infection | 1.50 (0.31-5.71) | .571 |
| Prosthetic joint infection | 4.51 (0.74-27.17) | .099 |
| Deep vein thrombosis | 4.86 (2.10-11.81) | <.001a |
| Pulmonary embolism | 6.27 (2.57-16.71) | <.001a |
| Acute kidney injury | 4.03 (2.65-6.17) | <.001a |
| Cardiac arrest | 10.71 (2.57-51.92) | .003a |
| Wound disruption | 1.86 (0.73-4.47) | .172 |
| Hematoma | N/A | N/A |
| Nerve injury | N/A | N/A |
| Pneumonia | 25.38 (16.66-39.65) | <.001a |
| Urinary tract infection | 1.99 (1.33-2.97) | <.001a |
| All complicationsb | 3.36 (2.47-4.59) | <.001a |
TJA, total joint arthroplasty; OR, odds ratio; CI, confidence interval; N/A, not applicable.
Bold values indicate statistical significance of P < .05.
a
Indicates statistical significance of P < .05.
b
Includes rate of all complications, excluding pneumonia.